© Reuters. FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake/File Photo
WASHINGTON (Reuters) – Illumina Inc (NASDAQ:) filed an appeal late on Monday against an order by the U.S. Federal Trade Commission, which is demanding that the company divest cancer diagnostic test maker Grail Inc because of concern that its ownership would stifle competition in the U.S. market for cancer tests.
Silver Place/iStock by way of Getty Photographs Pay attention right here or on the go by way of Apple Podcasts...
This text was written byComply withNow retired, I'm an income-oriented investor searching for excessive yield earnings to assist my life-style...
This text was written byComply withAustin Rogers is a REIT specialist with an expert background in industrial actual property. He...
2This is the discussion board for every day political dialogue on In search of Alpha. A brand new model is...
Operator Good day, and thanks for standing by. Welcome to the WaFd Fourth Quarter and Fiscal 12 months 2025 Outcomes...
NicoElNino/iStock through Getty Photos Pricey Companions, As you understand, I favor to NOT write each quarter because of the long-term...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
